Project Grant HT94252510137
Award Date
5/1/25
Completion Date
4/30/28
Dollars Obligated
$823K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
New York, NY 10032, USA
Similar Awards
The Trustees of Columbia University in New York City received a $243,000 Project Grant award from the Department of the Army Medical Command. The grant was awarded under the Military Medical Research and Development program (CFDA 12.420) to support the project "KCC2 DYSFUNCTION ENHANCES SYNAPTIC EXCITABILITY OF CYTOMEGALIC NEURONS IN TSC" from June 10, 2021 to June 9, 2023.
The Military Medical Research and Development program aims to transform military and public health through...
This $1,493,233 federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) will fund a research project at The Trustees of Columbia University in the City of New York to evaluate gene therapy as a treatment for cognitive defects in a non-human primate model of Parkinson's disease. The award has a performance period from November 15, 2024 to November 14, 2027. The university's Health Sciences Division will lead this innovative...
The Trustees of Columbia University in the City of New York will research autophagy induction as a novel therapeutic strategy for tuberous sclerosis complex-associated cognitive and autistic social deficits under a $810,000 Project Grant from the Department of the Army Medical Command. The grant was awarded on September 1, 2022 and runs through August 31, 2025.
The funding supports research that aligns with the Military Medical Research and Development program (CFDA 12.420) to investigate...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) is supporting research into the role of SUMO conjugation in Alzheimer's disease-related impairment of synaptic function and memory following traumatic brain injury (TBI). The $750,000 award to The Trustees of Columbia University in the City of New York will fund a collaborative project with researchers at the University of Toronto and Istituto di Ricerche...
The Defense Health Agency awarded a $1,695,794 Project Grant to The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division, to develop a state-of-the-art microbur-driven non-absorbable epithelial SERT antagonist to treat anxiety and depression in military members and the general public. The grant is funded through the Military Medical Research and Development (CFDA 12.420) program, which supports basic, applied, and advanced biomedical research...
The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division, received a $567,654 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). This funding supports spatial profiling of early, osimertinib-resistant brain lesions in EGFR-mutant lung cancer models over the 2-year period from July 1, 2023 to June 30, 2025. Through this grant, Columbia University will conduct biomedical...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $2,056,250 Project Grant to The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division, for the project "TARGETING CERVICAL EPIDURAL SPINAL CORD STIMULATION FOR FUNCTIONAL RECOVERY". The award period runs from Sep 1, 2024 to Aug 31, 2027. The grant supports investigative research aimed at improving health outcomes for military...
The Trustees of Columbia University in the City of New York will receive $1,619,986 from the Department of the Army Medical Command under a two-year Project Grant award to support preclinical characterization of Prosetin, a brain-penetrant MAP4K inhibitor for treating ALS. The grant was awarded on May 1, 2021 under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform military and public health care...
The Washington University received a $236,250 project grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant funding supports research from July 1, 2021 to June 30, 2023 to study the role of blood-brain barrier dysfunction in epilepsy associated with tuberous sclerosis complex. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical...
The University of Illinois received a $237,899 Project Grant from the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct a research project titled "USING SENSORY PROCESSING TO IDENTIFY NEURAL CIRCUIT DEFICITS AND NOVEL TREATMENT STRATEGIES IN A RAT MODEL OF TSC". The research aims to transform healthcare for Service Members and the American public through innovative and impactful biomedical research. The award is for the project...